(Q35150781)

6 August 2017

1 reference

title

Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy (English)

1 reference

6 August 2017

1 reference

2

Bridget Zimmerman

1 reference

6 August 2017

1

Sohan Singh Hayreh

1 reference

6 August 2017

publication date

1 June 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

110

1 reference

6 August 2017

issue

6

1 reference

6 August 2017

page(s)

1204-1215

1 reference

Treatment of temporal arteritis with adrenal corticosteroids; results in fifty-five cases in which lesion was proved at biopsy

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

1 reference

7 January 2021

Ischaemic optic neuropathy. The clinical profile and history

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

Giant-cell arteritis, temporal arteritis and polymyalgia rheumatica. A retrospective study of 63 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

Temporal arteritis--progressive affection of vision during high-level corticosteroid therapy. A case report

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

Prognosis and management of polymyalgia rheumatica

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients).

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

Progressive Anterior Ischemic Optic Neuropathy due to Giant Cell Arteritis Despite High-Dose Intravenous Corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

Giant cell arteritis: loss of vision during corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

Prevention of blindness in giant cell arteritis by corticosteroid treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

Visual Recovery in Two Patients after Intravenous Methylprednisolone Treatment of Central Retinal Artery Occlusion Secondary to Giant-cell Arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

Visual prognosis in giant cell arteritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

Giant cell arteritis. Corticosteroids, temporal artery biopsy, and blindness.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

Progressive visual loss from giant cell arteritis despite high-dose intravenous methylprednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

Bilateral ocular ischemic syndrome secondary to giant cell arteritis progressing despite corticosteroid treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

Occult giant cell arteritis: ocular manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

Steroid therapy for visual loss in patients with giant-cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

Giant cell arteritis: validity and reliability of various diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

Anterior ischaemic optic neuropathy. Differentiation of arteritic from non-arteritic type and its management

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

Anterior ischaemic optic neuropathy. II. Fundus on ophthalmoscopy and fluorescein angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

Ocular manifestations of giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

Blood supply of the optic nerve head and its role in optic atrophy, glaucoma, and oedema of the optic disc

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

The 1994 Von Sallman Lecture. The optic nerve head circulation in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

Anterior ischemic optic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

Inter-individual variation in blood supply of the optic nerve head. Its importance in various ischemic disorders of the optic nerve head, and glaucoma, low-tension glaucoma and allied disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

A fatal case of giant-cell or temporal arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

The visual changes in temporal (giant-cell) arteritis. Report of a case with autopsy findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

Ciliary artery involvement in giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

Histopathology of ischemic optic neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

Ischemic papilledema in giant-cell arteritis. Mucopolysaccharide deposition with normal intraocular pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

The central artery of the retina. I. Origin and course

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

THE OPHTHALMIC ARTERY: III. BRANCHES.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

Temporal arteritis; a generalized vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900228-8

7 January 2021

10.1016/S0161-6420(03)00228-8

Identifiers

DOI

1 reference

6 August 2017

1 reference